We are talking about products which saves lives not the normal antibiotics or pain killers. The MSB products in the pipeline are potentially billion dollar revenue earners. Hence your valuation is grossly understated. You add in patents and goodwill over the years and potential profits, we are looking at figures that are pretty healthy. The aGVHD is a small start and the there are bigger and better things to come. What we need now is a partnership and I do hope hope that Management is now in the process of signing the dotted lines.
MSB Price at posting:
$1.53 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)